CluenexReinsurance Group of America RGA
Reinsurance Group of America scores weak on business quality (4.3 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Reinsurance Group of America does
Reinsurance Group of America provides life and health reinsurance, helping primary insurers manage mortality risk and capital requirements by taking on blocks of their policies in exchange for premium payments. The company is leaning into favorable medical and rate trends to capture more business from primary insurers seeking balance sheet relief.
- What it does best
RGA scales its life reinsurance underwriting across global markets, generating $26.1 billion in revenue with an ROE of 11.3%. This deep underwriting expertise and established client trust across multiple international jurisdictions make it difficult for new entrants to quickly replicate its book of business.
- The main risk
Mortality spikes or adverse medical claims remain the primary operational threat. Because the firm absorbs large blocks of life and health insurance risks, unexpected health trends can directly compress its 9.4% operating margin.
Quality, check by check
Scored against its own industry, from company filings.
Operating margins rest at 9.4% alongside a 5.8% net margin, reflecting stable baseline earnings. However, ranking in the 8th sector percentile for operating margin shows that increased scale does not easily translate into outsized pricing power.
The company holds a narrow moat built on long-standing relationships with primary life insurers globally. Its operating margin sits in the 8th sector percentile, reflecting a thin competitive barrier where pricing pressure easily impacts returns.
Revenue reached $26.1B with a growth rate of 7.2%, landing in the middle of the pack at the 49th sector percentile. This top-line expansion continues a steady upward climb from past annual revenue figures.
Total debt sits at $5.7B against $4.2B in cash, while interest coverage of 6.2x keeps debt servicing manageable. Cash generation remains active with operating cash flow at $5.2B, pointing to stable financial footing.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
1 sold $2.1M outside pre-planned sales.
Our sealed record on RGA
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Reinsurance Group of America scores weak on the Cluenex quality check (4.3 of 10), measured against its own industry. Profitability is weak, moat weak, growth steady and financial health fair.
In the last 90 days of SEC Form 4 filings: 1 sold $2.1M outside pre-planned sales.
Nov 5, 2026, after the close.
See RGA today
- Today's verdict on RGA, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Reinsurance Group of America (RGA)”, https://cluenex.com/stocks/rga/, data as of Oct 10, 2026.